Clinical Trials Directory

Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants

Follow-up of GANI_MED Cardio Cohorts

Oral Health for Healthy Cognitive Aging

Multicenter Cohort Study on Osteoporosis

Prospective Cohort Study of Rapid Response Team

Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

Multimodal Imaging of Subchondral Bone in Knee Osteoarthritis : Predictive Model

Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

"The Study of Biological Prosthetic Heart Valves With the Easy Change System"

Biomarkers in Liver Failure

Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer

Evaluating Alcohol Use in Alcoholic Liver Disease

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC

Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless

Proton Therapy Patient Registry

Autologous Stem Cell Study for Adult TBI (Phase 2b)

A Study of LY3200882 in Participants With Solid Tumors

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

Ipilimumab for Head and Neck Cancer Patients

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).

A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

Effect of Intermittent Hypoxia in Healthy Individuals

Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases

Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours

IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Late Onset Alzheimer's Disease

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

Prognosis of Paroxysmal Kinesigenic Choreoathetosis in Korea

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

Study of Food Aversion in Patients With Anorexia Nervosa

Expectations Regarding Mobility and Self-Care

Visualizing Beta Cells in Patients With a History of Gestational Diabetes

Trial Of Pembrolizumab And Nintedanib

Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer